The main presentations will be given by:
Morag Maclean, Edinburgh Clinical Trials Unit, “Roles and responsibilities in investigator-led studies”
Ann Scott, OA Regulatory, “Overview of biological medicines and considerations when preparing the IMP/CMC dossier”
These will be followed by tea and coffee, and a roundtable discussion of serialisation requirements (Falsified Medicines Directive) and Brexit.
Member - free
Non-members - £45 (includes 2 months of complimentary TOPRA membership)